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Abstract: Efforts to use traditional native tissue strategies and reduce the use of meshes have been
made in several countries. Combining native tissue repair with sufficient mesh applied apical
repair might provide a means of effective treatment. The study group did perform and publish
a randomized trial focusing on the combination of traditional native tissue repair with pectopexy
or sacrocolpopexy and observed no severe or hitherto unknown risks for patients (Noé G.K. J
Endourol 2015;29(2):210–215). The short-term follow-up of this international multicenter study
carried out now is presented in this article. Material and Methods: Eleven clinics and 13 surgeons
in four European counties participated in the trial. In order to ensure a standardized approach and
obtain comparable data, all surgeons were obliged to follow a standardized approach for pectopexy,
focusing on the area of fixation and the use of a prefabricated mesh (PVDF PRP 3 × 15 Dynamesh).
The mesh was solely used for apical repair. All other clinically relevant defects were treated with
native tissue repair. Colposuspension or TVT were used for the treatment of incontinence. Data
were collected independently for 14 months on a secured server; 501 surgeries were registered
and evaluated. Two hundred and sixty-four patients out of 479 (55.1%) returned for the physical
examination and interview after 12–18 months. Main Outcome and Results: The mean duration
of follow-up was 15 months. The overall success of apical repair was rated positively by 96.9%,
and the satisfaction score was rated positively by 95.5%. A positive general recommendation was
expressed by 95.1% of patients. Pelvic pressure was reduced in 95.2%, pain in 98.0%, and urgency in
86.0% of patients. No major complications, mesh exposure, or mesh complication occurred during
the follow-up period. Conclusion: In clinical routine, pectopexy and concomitant surgery, mainly
using native tissue approaches, resulted in high satisfaction rates and favorable clinical findings.
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The procedure may also be recommended for use by general urogynecological practitioners with
experience in laparoscopy.
Keywords: prolapse; pelvic floor; laparoscopy; native tissue; pectopexy
1. Introduction
Due to controversies about the use of meshes, native tissue repair in pelvic surgery
has currently rebecome the matter of choice in several countries. Native tissue repair was
considered to be insufficient for a long period of time. However, several publications have
shown that, from a clinical perspective, it provides better outcomes than meshes in the
long term. In fact, the patients’ symptoms are improved to a much greater extent compared
to the assessment of the sheer anatomical results [1–3]. Various vaginal or abdominal
techniques (Manchester; sacrospinous fixation; high uterosacral fixation etc.) have been
suggested for the restoration of apical support. To date, we lack validated data about the
adequacy of these approaches. Sacral colpopexy with mesh is a frequently used technique
in laparoscopy and has been evaluated in several studies. Due to the disadvantages of
the approach (see below), our group devised the procedure of laparoscopic pectopexy in
2007 [4].
The so-called gold standard of laparoscopic sacral colpopexy (LSC) is based on several
decades of extensive experience. The introduction of alloplastic material to fill the gap
between the vagina and the sacrum accelerated the acceptance of the technique [5]. Exten-
sive data have been reported from single-center studies, but a prospective multicenter trial
comparing access and quality has not been published so far [6–8].
LSC commonly employs a y-shaped mesh deeply covering the total posterior length
of the vagina and the anterior wall next to the bladder neck [9,10]. Comparison with
published data is rendered difficult by the manifold approaches currently in use. Therefore,
our group did focus on the use of mesh material only for apical support and did repair
other defects with native tissue strategies [11].
Using pectopexy as apical support in combination with native tissue may reduce the
risk of defecation disorders, which occur frequently after LSC. Additionally, mesh-related
problems such as exposure at the vaginal wall were reduced [12].
De novo defecation disorders are anticipated in 17–34% of cases after LSC [9,13–17].
Slow intestinal transit, chronic flatulence, pain during defecation, and mild to severe
constipation are the main symptoms reported in the literature. Published data on pectopexy
have indicated the benefits of offering a standardized alternative option to LSC with the
potential of reducing the risk of defecation disorders and bowel constriction by the mesh
material, especially in obese patients [12]. The combination of native tissue repair and
sufficient apical support leads to a low rate of de novo stress urinary incontinence (SUI)
(4.5–7%) as well as minimal use of mesh material [3,12].
The present multicenter trial was performed to evaluate the effectiveness of the
approach in general use by trained surgeons and determine the results of native tissue
repair combined with apical mesh support in different hospitals and by different surgeons.
2. Materials and Methods
The study was initiated at 11 hospitals with 13 surgeons in four European counties.
In order to ensure a standardized approach and obtain comparable data, all centers were
instructed to use a prefabricated mesh (Dynamesh PRP 3 × 15) (approximately 25 cm2).
In pectopexy, the mesh for apical support is fixed bilaterally at the pectineal ligament and
anchored by sutures close to the crossing psoas muscle. This provides a fixation point at
the level of the first sacral vertebra. Placement of the tape does not interfere with organs,
vessels or nerves, and the defined fixation point ensures correct anatomical positioning
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of the vaginal axis. Owing to its position, the tape does not disturb the rectum or the
hypogastric plexus. The diameter of the lower pelvis is not reduced by the technique.
Surgeons were trained by experts from the center at which the technique was devel-
oped, and data were collected on a secure server at the University of Wuerzburg. Every
needed to have performed a minimum of 20 procedures before entering the study. All of
the surgeons had private access to the server and could collect their data independently.
All patients who required surgical treatment (conservative treatment was either insuf-
ficient or was not accepted by the patient) were included in the study, except those with
contraindications for laparoscopy. In accordance with common practice at the majority
of the hospitals, the Baden-Walker classification (grades 1 to 4) was used to describe the
defects. A distinction was made between apical defects, cystocele midline—cystocele
lateral defects, and posterior defects. A modified version of the ICIQ-VS (International
Consultation on Incontinence Questionnaire—Vaginal Symptoms) questionnaire was used
to assess clinical complaints. The group did focus on complaints such as pelvic pressure,
SUI, urgency, stool bulking/constipation, pain, and sexual impairment. Table 1 shows the
rating of the complaints. Obstetric data and the patients’ histories of previous surgery,
especially hysterectomy and cesarean section, were registered. Stress urinary incontinence
(SUI) was stratified from grade 1 to 3, according to Stamey’s definition.
Table 1. Measurement of symptoms by the questionnaire based on International Consultation on
Incontinence Questionnaire—Vaginal Symptoms (ICIQ-VS).
Measurement
Complaints Positive Negative
Pelvic pressure Daily or regularly Rare or no pressure
SUI Stratification by Steamy No SUI
Urgency Positive answer and bothersome forthe patient
No nycturia or frequency, no
urge feeling
Stool bulking Feeling of pressure in the lower rectum No rectal problems
Constipation Need for laxatives, slow transit Normal defecation
Pain Pain in the pelvis No pain
Concomitant surgeries, whether by the vaginal or laparoscopic approach, total operat-
ing times, and the time used for pectopexy, were registered. Intraoperative complications
and postoperative data such as the duration of hospital stays, early—and late-onset infec-
tion (14 days after surgery), and wound infection were recorded in the database.
A total of 501 patients were registered in 14 months. Surgical data were analyzed and
have been published recently [11]. Telephone interviews were not included in the evalua-
tion. IBM SPSS statistics and Sigma plot Statistics (Systat Software, Inc., D-40699 Erkrath,
Germany) were used for statistical evaluation.
3. Results
After the scheduled 14 months of data collection, 501 patients were registered on the
server. Surgical and early complications have been reported in a previous publication [11].
Follow-up was performed 12–18 months after surgery (mean, 15 ± 2 months). A large num-
ber of patients, especially those at the main center, had to travel long distances (>100 km)
or had difficulties arranging their transport, which had a negative impact on evaluation
rates. Two hospitals, which had contributed two and 20 patients each, did not participate
in the follow-up. More than 93% of the patients answered the follow-up inquiry. More
than half of the patients who could not arrange to come answered the questionnaire, the
others responded positively by phone. Only 7% did not react. Two hundred and sixty-four
of 479 patients (55.1%) underwent a physical examination and were followed up with
the questionnaire used prior to surgery. A distinction was made between de novo and
persistent complaints and defects.
The distribution of concomitant surgeries in the examined group was similar to that
in the entire study group. Table 2 shows the total and relative numbers for all surgical
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approaches in the entire group compared to the examined group. The distribution of defects
was similar in both groups (Table 3). Table 4 shows primary symptoms preoperatively and
during follow-up.







Pectopexy 501 100 264 100
Laparoscopic cystocele repair 173 34.5 83 31.5
Laparoscopic posterior repair 132 26.3 58 22.0
Vaginal anterior repair 68 13.6 50 18.9
Vaginal posterior repair 59 11.8 41 15.5
Laparoscopic lateral repair 115 22,9 50 18,9
Burch colposuspension 64 12.8 34 12.9
Vaginal tape 2 0.4 2 0.76
LSH 313 62.5 175 66.3
TLH 5 1.0 2 0.76
Table 3. Distribution of defects in the total study group compared to the examination group.
Defect Total Group Examination Group
Apex grade 2 57% 52%
Apex grade 3 and 4 37% 39%
Cystocele grade 2 and 3 60% 59%
Posterior grade 2 12% 11%
Posterior grade 3 13% 14%
Table 4. Impact of surgery on complaints in the follow-up group before and after surgery.
Pre-Surgery Follow-Up De Novo Persistent
Pelvic pressure 86.7% (229) 9.8% (26) 5.7% (15) 4.1% (11)
Pain 18.9% (50) 2.7% (7) 2.3% (6) 0.4% (1)
Urgency 51.7% (136) 11.4% (30) 4.2% (11) 14% (19)
Sexual impairment 15.9% (42) 3.4% (9) 2.7% (6) 7.1% (3)
Stool bulking/ 11.2% (28) 3.2% (8) 0.4% (1) 25.0% (7)
3.1. Pelvic Pressure
Only 4.1% of patients with a preoperative sensation of pelvic pressure reported no
significant change after surgery (chi-square p < 0.001), while 5.7% reported de novo pressure
due to relapse or de novo changes. Previous symptoms were reduced in 95.9% of patients.
3.2. Urgency
50% of the patients included in the study reported urgency before surgery, whereas
86% of this group had no urgency after surgery (chi-square p < 0.001). De novo urgency
was registered in 4.2% of patients. 25% (34) had an additional loss of urine prior to surgery.
One (9%) of the patients with de novo urgency also had a first-degree loss of urine. In
the group with urgency persistence, 3 (16%) women with persistent grade 1 incontinence
were registered.
3.3. Sexual Impairment
Sexual impairment was considered relevant by 16.8% of the total cohort (15.9% of the
follow-up group). Only 7.14% of patients complained of persistence after surgery.
3.4. SUI
Twenty-four percent of the patients reported SUI before surgery. SUI was rated: grade
1 by 25%, grade 2 by 66%, and grade 3 by 9% of patients. Of those who underwent
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additional surgery (colposuspension n = 43), 72.1% of patients were dry, and 93% were
improved; 7% reported persistence of previous symptoms after surgery. Thirteen patients
did not receive any treatment for incontinence; 53.4% were dry after prolapse surgery;
and 30.8% reported persistence of their previous incontinence. Only two cases (0.8%) of
de-novo incontinence were identified in the whole cohort.
3.5. Stool Bulking and Constipation
Preoperatively, 11.2% of patients experienced stool bulking or constipation. We noted
persistence in 25.0%, and one patient with de novo symptoms.
Since a slight degree of under-correction of level I. (between grade 0–1) was agreed
upon in order to avoid the side effects of over-correction, grade 1 was considered to indicate
cure of presurgical stages 2 and above. Cure was registered in 94.3% of patients, while
96.6% were either cured or improved.
3.6. Level II
Out of 35 untreated grade 1 cystoceles, 15 (42%) persisted while two (6%) deteriorated
(Grad 2). 133 patients with a grade 2 or higher midline defect received an additional native
tissue repair. 121 (91%) showed cure or improvement, while 12 persisted or worsened.
99 patients with clinically relevant posterior defects were treated with additional
native tissue repair. In this group, 94 (95%) showed an improvement or cure.
When asked “Would you recommend the treatment to a relative?” the question was
answered positively by 95.1% of patients. The mean rating on an analogue satisfaction
scale from 1–10 was 8.7. Overall, 90.2% of patients gave a rating between 7 and 10. The
reasons for not recommending the treatment were pelvic pressure (persistent or de novo)
(eight cases), de novo pain (two cases), and de novo sexual impairment (three cases, two of
which involved persistent incontinence).
3.7. Complications
Three lymphatic seromas at the lateral suspension site were treated by laparoscopy.
One TVT was placed after 7 months because of incontinence. Two re-interventions were
performed by the laparoscopic approach because of early level 1 recurrence. One patient
with urinary retention received medical treatment. One de novo enterocele and one de
novo cystocele were operated on during the follow-up period. No mesh exposure or mesh
complication was observed during follow-up.
4. Discussion
4.1. Main Findings
Previous publications have indicated that pectopexy is safe and can be incorporated in
clinical routine [11,12]. Since controversies concerning meshes may also affect abdominal
techniques with the extended use of meshes (deep anterior or posterior mesh placement),
Our group collected data on reduced mesh use adding to the effectiveness of pectopexy. In
this study, 15 cm of PVDF tape (Dynamesh PRP 3 × 15) were used solely for apical support
(approximately 25 cm2). In a computer simulation, Bhattarai et al. showed that bilateral
fixation in pectopexy permits better physiological positioning of the bladder and vaginal
cuff than unilateral sacral colpopexy during the Valsalva maneuver [18].
The anchor point of pectopexy lies 1–2 cm above the natural apex and does not allow
for correction of a cystocele or a posterior defect by pulling the vagina cranially. Therefore,
in this study, our group did combine apical support with concomitant repair, depending
on individual defects and disorders (Table 2). Notably, no additional mesh was used for
cystocele, rectocele, or enterocele repair.
The results were compared with those of LSC, mainly performed with deep mesh
fixation [9,10,19]. The comparison was rendered difficult by inconsistent results and the
absence of prospective multicenter trials. Therefore, the group did compare its findings
mainly with reports from single-center studies, which comprised small sample sizes and
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patients who did not undergo physical examination. The majority of published stud-
ies have been focused on anatomical changes or outcomes; clinical findings were given
less importance.
The cure rate in this study for level 1 was 94.3%, while 96.6% of patients were either
cured or improved. This is a confirmation of previous data [12]. Similar rates have been
reported for LSC (94–100%) [10,20–22].
The primary symptom was pelvic pressure and bulging, which occurred in 86.7%
(n = 229). Persistence of this symptom was noted in 4.1% of patients. Symptoms were
reduced in 95.2% (p ≤ 0.001 for the chi square test). De novo symptoms, mainly due to
de novo pelvic floor defects, were reported by 5.7% of patients. Liedel et al., who studied
277 patients, noted reduced symptoms in 82.7% (p = 0.00001) after vaginal pelvic floor
surgery [23]. In retrospective data, Bojahr et al. noted a reduction of symptoms in 90.7% of
patients after LSC [24].
This study did register a reduction of pain in 98% of patients, whereas Liedel et al.
observed the same in 53.1%, and Bojahr et al. in 44% of patients. These diverse outcomes
may have been due to different interpretations of the sensation of pain.
Of the follow-up group, 51.7% (136) of patients complained of urgency and frequency
before surgery. This symptom was reduced in 86% of patients during follow-up; 4.2%
complained of de novo urgency. Several studies have focused on urgency and prolapse.
Whilst Malanowska et al. reported a reduction of symptoms in 76% and a de novo rate of
2.6% of patients for the lateral suspension technique, Illiano noted a reduction of symptoms
in 73.6% of patients after LSC and Rexhepi et al. observed a reduction in 67% of patients
who were treated with bilateral LSC. Compared to published success rates for pectopexy,
we achieved excellent results [25–27].
The measurement of sexual impairment was one of the most problematic issues. Pelvic
floor defects are associated with a combination of anatomical obstacles and psychological
embarrassment. Prolapse problems could not be distinguished easily from interpersonal
incompatibility in sexual relationships. The data are quite heterogeneous. Our group
did observe different outcomes in its studies; 15.9% of the follow-up cohort complained
of sexual impairment before surgery. The reduction registered in 92.9% of patients was
surprisingly high, but a de novo problem occurred in 2.7%. Half of the latter patients
would not recommend the procedure because of their de novo sexual impairment.
This study measured a reduction of stool bulking and constipation in 75% of patients
(p < 0.001). Whilst studies addressing vaginal repair have reported a reduction of symptoms
in 66% of patients after vaginal repair, most LSC studies mention an increased rate during
follow-up [16,17,23,24,28,29]. As LSC is known to be associated with bowel symptoms,
vaginal repair, as well as pectopexy, appear to significantly improve this complaint. The
results support previous findings from our first randomized trial [12].
De novo incontinence occurred in 0.8% of cases, and 56 patients had relevant incon-
tinence before surgery. A total of 43 patients were treated simultaneously with colposus-
pension, whereas 13 did not receive additional treatment. Improvement was registered
in 93% of the first group, but only 53.4% of the second group (p = 0.003; Fisher’s exact
test). High incontinence rates (5–40%) have been reported after LSC. Some authors recom-
mend adding Burch colposuspension to the surgical strategy. However, this topic remains
controversial [20,24,30–32]. Our findings support simultaneous treatment in a multiple
compartment setting.
There are some long-term studies on sacropexy or hysterosacropexy available which
report a high level of safety in the procedures. The latter technique enables an exposure rate
of only 0.4% with a median observation of 46 months (multicenter questionnaire study).
Nightingale and Phillips examined 93 of 112 patients over 9 years of age (mean 6 years
follow-up) and reported only one mesh complication (bowel obstruction). We did not find
any mesh complication yet and hope to publish a long term follow up soon [33,34].
J. Clin. Med. 2021, 10, 217 7 of 9
4.2. Strengths and Limitations
The multicenter setting provided a large cohort of patients who could be studied
prospectively at a large number of international centers. Clinically relevant anatomical,
functional, and subjective findings are reported here. Due to the heterogeneity of clinical
practices in four countries and 11 centers, and to ensure the comparability of data, we
used a standardized questionnaire designed for the study in addition to routine data
collection. This limits the comparability of the present investigation with other publications
based on questionnaires provided by the International Urogynecology Association (IUGA)
or International Continence Society (ICS). An international trial entails the inclusion of
different experiences and diverse traditions. We could standardize the technique for
pectopexy and laparoscopic cystocele and rectocele repair, but the vaginal approaches were
based on local experience. The effect of these differences on the collected data could not
be measured.
4.3. Interpretation
A positive recommendation rate of 95.1% and a mean satisfaction rate of 8.7 (from 1 to
10) expressed the high degree of clinical acceptance by the patients. Figure 1 shows the
distribution of the rating scale for the entire treatment. The negative recommendations
resulted from de novo sexual impairment (3), de novo defects, and relapse. Complications
such as infections or seroma were widely accepted.




Figure 1. Rating scale for patients’ satisfaction with their treatment. 
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ticenter study provides valid results because of the large sample size and the standardized 
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tification of those patients who require additional mesh for level 2 and 3 treatment. 
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5. Conclusions
Pectopexy combining apical support with a prefabricated PVDF tape and native tissue
repair for level 2 and 3 defects yielded favorable clinical outcomes and a low re-intervention
rate after a mean follow-up period of 15 months. A prospective international ulticenter
study provides valid results because of the large sample size and the standardi proce-
dures performe by i pendent surgeons. Given the favorabl results and the low rates
of side effects, the approach may be recommended as an alternative to LSC for experienced
J. Clin. Med. 2021, 10, 217 8 of 9
surgeons. It provides the option of reducing mesh use by combining adequate apical
support with native tissue repair. The long-term follow-up should permit the identification
of those patients who require additional mesh for level 2 and 3 treatment.
Author Contributions: Concept, analysis, G.K.N.; data collection, G.K.N., S.S., T.P., U.F., A.K.,
H.-H.A., S.B., P.P.M., M.G., B.D.V., Z.T., R.G.U., M.A.; editing, Z.T.; planning, writing, G.K.N. and
M.A. All authors have read and agreed to the published version of the manuscript.
Funding: FEG Textieltechnik; Aachen (Dynamesh) paid the rental fee for the use of the server at the
University of Würzburg.
Institutional Review Board Statement: Ethics approval was obtained from the ethics committee of
the University of Witten-Herdecke (committee in accordance with the revised Declaration of Helsinki,
1975) (Approval number 156/2017, October 2017).
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
Data Availability Statement: Data available on request due to restrictions e.g., privacy or ethical.
Conflicts of Interest: Günter Noé and Michael Anapolski received support for accommodation from
Dynamesh FEG Aachen; the remaining authors have no conflict of interests to disclose.
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